We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
Cap. Flow
-$193M
Cap. Flow %
-3.9%
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98

Top Buys

Rank Stock Value
1
MANH icon
Manhattan Associates
MANH
+$33.6M
2
AMZN icon
Amazon
AMZN
+$32.3M
3
CEB
CEB Inc.
CEB
+$27.7M
4
GILD icon
Gilead Sciences
GILD
+$27.3M
5
MRK icon
Merck
MRK
+$25.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$49.9M
2
TWX
Time Warner Inc
TWX
+$30.5M
3
SRCL
Stericycle Inc
SRCL
+$29.3M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$25M
5
SUN icon
Sunoco
SUN
+$21.8M

Sector Composition

Rank Sector Weight
1 Healthcare 19.16%
2 Financials 16.84%
3 Consumer Discretionary 14.26%
4 Technology 13.32%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATOS icon
526
Atossa Therapeutics
ATOS
$26.3M
$8K ﹤0.01%
4
– –
QMM
527
DELISTED
QUATERRA RESOURCES INC LTD
QMM
$8K ﹤0.01%
136,175
– –
HK
528
DELISTED
Halcon Resources Corporation
HK
$8K ﹤0.01%
87
– –
GMO
529
DELISTED
General Moly, Inc.
GMO
$4K ﹤0.01%
13,518
– –
ACTG icon
530
Acacia Research
ACTG
$438M
– –
-12,440
Closed -$109K
ADSK icon
531
Autodesk
ADSK
$57.1B
– –
-4,314
Closed -$216K
ASHR icon
532
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.57B
– –
-14,650
Closed -$674K
BHC icon
533
Bausch Health
BHC
$2.36B
– –
-1,050
Closed -$233K
BKD icon
534
Brookdale Senior Living
BKD
$2.89B
– –
-31,260
Closed -$1.08M
BMO icon
535
Bank of Montreal
BMO
$120B
– –
-3,462
Closed -$205K
CLDX icon
536
Celldex Therapeutics
CLDX
$3.18B
– –
-749
Closed -$283K
COR icon
537
Cencora
COR
$61.3B
– –
-2,855
Closed -$304K
CPA icon
538
Copa Holdings
CPA
$5.94B
– –
-27,578
Closed -$2.28M
CSIQ icon
539
Canadian Solar
CSIQ
$949M
– –
-15,700
Closed -$449K
CSV icon
540
Carriage Services
CSV
$544M
– –
-31,704
Closed -$757K
ESPR
541
DELISTED
Esperion Therapeutics
ESPR
– –
-2,963
Closed -$242K
EWS icon
542
iShares MSCI Singapore ETF
EWS
$1.23B
– –
-8,258
Closed -$208K
FCX icon
543
Freeport-McMoran
FCX
$113B
– –
-49,467
Closed -$921K
FUN icon
544
Cedar Fair
FUN
$1.63B
– –
-4,423
Closed -$241K
FXI icon
545
iShares China Large-Cap ETF
FXI
$4.2B
– –
-10,415
Closed -$480K
GLPI icon
546
Gaming and Leisure Properties
GLPI
$12.3B
– –
-6,000
Closed -$220K
GS icon
547
Goldman Sachs
GS
$303B
– –
-1,048
Closed -$219K
HOG icon
548
Harley-Davidson
HOG
$2.9B
– –
-3,767
Closed -$212K
IBB icon
549
iShares Biotechnology ETF
IBB
$10.8B
– –
-4,725
Closed -$581K
IHF icon
550
iShares US Healthcare Providers ETF
IHF
$1.24B
– –
-20,150
Closed -$576K
20 21
22
23 24

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.

  • Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
  • Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
  • Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
  • Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
  • Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
  • Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
  • Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.

Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.